Many people think strokes happen without warning, but health experts say the body often sends important signals days or even ...
Asundexian plus antiplatelet therapy reduces IS risk in patients with noncardioembolic stroke or high-risk transient ischemic attack.
A major international trial suggests an experimental anti-clotting drug may lower the risk of repeat strokes without the ...
Zacks Investment Research on MSN
Bayer gets FDA priority review for asundexian NDA in stroke prevention
Bayer BAYRY announced that the FDA has accepted its new drug application (NDA) for its investigational, once-daily, oral ...
Strokes can happen in an instant and knowing the warning signs could save a life. Moayad Ismail, MD, Adult Medicine Physician ...
Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) ...
All the wonderful and most welcome signs of the new life surround us. (Sorry, allergy sufferers! I do feel your pain!) The ...
The FDA granted Priority Review to the novel Factor XIa inhibitor asundexian for secondary stroke prevention following an ischemic stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results